期刊的影响因子--文章列表

期刊文章列表
Xiaoyuan Mao^1,2,3,4，Xuan Wang⁵，Mingzhu Jin⁶，Qin Li^1,2,3,4，Jining Jia^1,2,3,4，Menghuan Li^5,7，Honghao Zhou^1,2,3,4，Zhaoqian Liu^1,2,3,4，Weilin Jin⁸，Yanli Zhao⁷，Zhong Luo⁵（Department of Clinical Pharmacology，Xiangya Hospital，Central South University；Institute of Clinical Pharmacology，Central South University，Hunan Key Laboratory of Pharmacogenetics；Engineering Research Center of Applied Technology of Pharmacogenomics，Ministry of Education；National Clinical Research Center for Geriatric Disorders；School of Life Science，Chongqing University；Department of Gynecology and Obstetrics，Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；Division of Chemistry and Biological Chemistry，School of Physical and Mathematical Sciences，Nanyang Technological University；Institute of Cancer Neuroscience，Medical Frontier Innovation Research Center，the First Hospital of Lanzhou University，the First Clinical Medical College of Lanzhou University）.Critical involvement of lysyl oxidase in seizure-induced neuronal damage through ERK-Alox5-dependent ferroptosis and its therapeutic implications[J].Acta Pharmaceutica Sinica B,2022,第9期 Yanqiu Gu，Rong Wang，Panpan Chen，Shengnan Li，Xinyi Chai^2,3，Chun Chen，Yue Liu^2,3，Yan Cao^2,3，Diya Lv^2,3，Zhanying Hong^2,3，Zhenyu Zhu^2,3，Yifeng Chai^2,3，Yongfang Yuan，Xiaofei Chen^2,3（Department of Pharmacy，Shanghai Ninth People’s Hospital，Shanghai Jiao Tong University，School of Medicine；School of Pharmacy，Naval Medical University (Second Military Medical University)；Shanghai Key Laboratory for Pharmaceutical Metabolite Research）.In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography[J].Acta Pharmaceutica Sinica B,2022,第9期 Jiulong Zhang¹，Xiaoyan Sun¹，Xiufeng Zhao²，Chunrong Yang³，Menghao Shi¹，Benzhuo Zhang⁴，Haiyang Hu¹，Mingxi Qiao¹，Dawei Chen¹，Xiuli Zhao¹（School of Pharmacy，Shenyang Pharmaceutical University；Department of Oncology，Affiliated Hongqi Hospital of Mudanjiang Medical College；Department of Pharmacy，Shantou University Medical College；Department of Neurology，The Second Affiliated Hospital of Mudanjiang Medical College）.Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy[J].Acta Pharmaceutica Sinica B,2022,第9期 Xiaojie Chen^1,2，Xudong Fan¹，Yue Zhang¹，Yinghui Wei¹，Hangsheng Zheng¹，Dandan Bao³，Hengwu Xu，Ji-Gang Piao^1,2,5，Fanzhu Li^1,2，Hongyue Zheng⁶（School of Pharmaceutical Sciences，Zhejiang Chinese Medical University；Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province，School of Pharmaceutical Sciences，Zhejiang Chinese Medical University；Department of Dermatology & Cosmetology，The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)；Department of Pharmacy，Jinhua People’s Hospital；Academy of Chinese Medical Sciences，Zhejiang Chinese Medical University；Libraries of Zhejiang Chinese Medical University，Zhejiang Chinese Medical University）.Cooperative coordination-mediated multi-component self-assembly of "all-in-one" nanospike theranostic nano-platform for MRI-guided synergistic therapy against breast cancer[J].Acta Pharmaceutica Sinica B,2022,第9期 Shaoxing Guan¹，Xi Chen²，Youhao Chen¹，Guohui Wan¹，Qibiao Su³，Heng Liang¹，Yunpeng Yang²，Wenfeng Fang²，Yan Huang²，Hongyun Zhao²，Wei Zhuang⁴，Shu Liu^1,2，Fei Wang⁵，Wei Feng¹，Xiaoxu Zhang¹，Min Huang¹，Xueding Wang¹，Li Zhang²（Laboratory of Drug Metabolism and Pharmacokinetics，School of Pharmaceutical Sciences，Sun Yat-sen University；State Key Laboratory of Oncology in South China，Collaborative Innovation Center for Cancer Medicine，Sun Yatsen University Cancer Center；College of Health Science，Guangdong Pharmaceutical University；Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Ersha Department of Pharmacy，the Second Affiliated Hospital of Guangzhou University of Chinese Medicine）.FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy[J].Acta Pharmaceutica Sinica B,2022,第9期 Xiaohong Cen¹，Baoqu Wang¹，Yuqing Liang¹，Yanlin Chen¹，Yu Xiao¹，Shaohua Du²，Kutty Selva Nandakumar¹，Hang Yin³，Shuwen Liu¹，Kui Cheng^1,2（Guangdong Provincial Key Laboratory of New Drug Screening and State Key Laboratory of Organ Failure Research，School of Pharmaceutical Sciences，Southern Medical University；Department of Musculoskeletal Oncology，the Third Affiliated Hospital of Southern Medical University；School of Pharmaceutical Sciences，Beijing Advanced Innovation Center for Structural Biology，Tsinghua-Peking Joint Center for Life Sciences，Tsinghua University）.Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation：A novel approach to atherosclerosis therapy[J].Acta Pharmaceutica Sinica B,2022,第9期 Jian Sun^1,2,3，Tongzhu Jin^1,2，Zhihui Niu^1,2，Jiayu Guo^1,2，Yingying Guo^1,2，Ruoxuan Yang^1,2，Qianqian Wang^1,2，Huiying Gao^1,2，Yuhan Zhang^1,2，Tianyu Li^1,2，Wenxin He⁴，Zhixin Li⁴，Wenchao Ma^1,2，Wei Su^1,2，Liangliang Li^1,2，Xingxing Fan⁵，Hongli Shan^1,2,6，Haihai Liang^1,2,6（Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China，Key Laboratory of Cardiovascular Research，Ministry of Education)，College of Pharmacy，Harbin Medical University；Northern Translational Medicine Research and Cooperation Center，Heilongjiang Academy of Medical Sciences，Harbin Medical University；Zhuhai People's Hospital，Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment，Zhuhai Hospital Affiliated with Jinan University，Jinan University；Department of Thoracic Surgery，Shanghai Pulmonary Hospital，Tongji University；State Key Laboratory of Quality Research in Chinese Medicine/Macau Institute for Applied Research in Medicine and Health，Macau University of Science and Technology；Research Unit of Noninfectious Chronic Diseases in Frigid Zone (2019RU070)，Chinese Academy of Medical Sciences）.LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation[J].Acta Pharmaceutica Sinica B,2022,第9期 Mengwen Huang¹，Miaomiao Zhang^1,2，Hongbin Zhu^1,3，Xiaojiao Du⁴，Jun Wang^1,2,5（School of Biomedical Sciences and Engineering，South China University of Technology，Guangzhou International Campus；National Engineering Research Center for Tissue Restoration and Reconstruction，South China University of Technology；Guangdong Provincial Key Laboratory of Biomedical Engineering，South China University of Technology；School of Medicine，South China University of Technology；Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education，South China University of Technology）.Mucosal vaccine delivery：A focus on the breakthrough of specific barriers[J].Acta Pharmaceutica Sinica B,2022,第9期 Fenglin Li¹，Yi Lai²，Jiayi Ye²，Madiha Saeed²，Yijing Dang¹，Zhifeng Zou¹，Fangmin Chen²，Wen Zhang¹，Zhiai Xu¹（School of Chemistry and Molecular Engineering，East China Normal University；State Key Laboratory of Drug Research & Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences）.Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma[J].Acta Pharmaceutica Sinica B,2022,第9期 Xiaonan Chen¹，Yiqing Zou¹，Shuqi Zhang¹，Pengchao Fang¹，Shuxuan Li¹，Pengyu Li¹，Yingying Sun¹，Gang Yuan^2,3，Haiyan Hu^1,4（Lab of Pharmaceutics，School of Pharmaceutical Sciences，Sun Yat-sen University；Phase Ⅰ Clinical Trial Center，the First Affiliated Hospital of Sun Yat-sen University；Department of Geriatrics，the First Affiliated Hospital of Sun Yat-sen University；Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery，Sun Yat-sen University）.Multi-functional vesicles improve Helicobacter pylori eradication by a comprehensive strategy based on complex pathological microenvironment[J].Acta Pharmaceutica Sinica B,2022,第9期 Chao Zheng^1,2，Wen Zhang^1,2，Jinming Wang³，Yihui Zhai^2,4，Fengqin Xiong^1,2，Ying Cai^2,4，Xiang Gong^1,2，Binyu Zhu^2,4，Helen He Zhu³，Hao Wang¹，Yaping Li^2,4,5，Pengcheng Zhang^2,6,4（China State Institute of Pharmaceutical Industry；State Key Laboratory of Drug Research & Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；State Key Laboratory of Oncogenes and Related Genes，Renji-Med-X Stem Cell Research Center，Department of Urology，Ren Ji Hospital，School of Medicine and School of Biomedical Engineering，Shanghai Jiao Tong University；University of Chinese Academy of Sciences；Bohai Rim Advanced Research Institute for Drug Discovery；Yantai Key Laboratory of Nanomedicine & Advanced Preparations，Yantai Institute of Materia Medica）.Lenvatinib-and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer[J].Acta Pharmaceutica Sinica B,2022,第9期 Lu Miao¹，Wei Zhou¹，Chunyu Yan¹，Yuebin Zhang²，Qinglong Qiao¹，Xuelian Zhou¹，Yingzhu Chen¹，Guangying Wang¹，Zhendong Guo³，Jun Liu³，Hailong Piao¹，Xia Pan⁴，Mengxue Yan⁴，Weijie Zhao⁴，Guohui Li²，Yueqing Li⁴，Zhaochao Xu¹（CAS Key Laboratory of Separation Science for Analytical Chemistry，Dalian Institute of Chemical Physics，Chinese Academy of Sciences；State Key Laboratory of Molecular Reaction Dynamics，Dalian Institute of Chemical Physics，Chinese Academy of Sciences；Institute of Military Veterinary Science，The Academy of Military Medical Science of PLA；State Key Laboratory of Fine Chemicals，Department of Pharmaceutical Sciences，School of Chemical Engineering，Dalian University of Technology）.Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD-ACE2 complexes in living cells by competitive binding[J].Acta Pharmaceutica Sinica B,2022,第9期 Robert Pomponio¹，Qi Tang²，Anthony Mei²，Anne Caron³，Bema Coulibaly³，Joachim Theilhaber⁴，Maximilian Rogers-Grazado⁴，Michele Sanicola-Nadel⁵，Souad Naimi³，Reza Olfati-Saber²，Cecile Combeau¹，Jack Pollard⁴，Tun Tun Lin⁵，Rui Wang¹（Sanofi Translational Medicine Early Development Cambridge；Sanofi Artificial Intelligence and Deep Analytics Data and Data Sciences；Sanofi Translational Science；Sanofi Precision Oncology Cambridge；Sanofi Oncology Early Development Cambridge）.An integrative approach of digital image analysis and transcriptome profiling to explore potential predictive biomarkers for TGFβ blockade therapy[J].Acta Pharmaceutica Sinica B,2022,第9期 Haijun Yu¹，Zhiyong Qian²（Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University，Collaborative Innovation Center of Biotherapy）.Editorial of Special Column on A New Era of Nanobiomaterial-based Drug Delivery[J].Acta Pharmaceutica Sinica B,2022,第9期 Zheng-Wei Zhang¹，Chun-Sheng Gao²，Heng Zhang³，Jian Yang^4,5，Ya-Ping Wang^4,5，Li-Bin Pan¹，Hang Yu¹，Chi-Yu He¹，Hai-Bin Luo⁶，Zhen-Xiong Zhao¹，Xin-Bo Zhou⁷，Yu-Li Wang²，Jie Fu¹，Pei Han¹，Yu-Hui Dong³，Gang Wang^4,5，Song Li⁶，Yan Wang¹，Jian-Dong Jiang¹，Wu Zhong⁷（State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Institute of Materia Medica，Chinese Academy of Medical Sciences/Peking Union Medical College；Beijing Institute of Pharmacology and Toxicology；Beijing Synchrotron Radiation Facility,Institute of High Energy Physics,Chinese Academy of Sciences；The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders，Beijing Anding Hospital,Capital Medical University；Advanced Innovation Center for Human Brain Protection,Capital Medical University；School of Pharmaceutical Sciences,Hainan University；National Engineering Research Center for the Emergence Drugs）.Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota[J].Acta Pharmaceutica Sinica B,2022,第8期 Wenfeng Jia¹，Rui Liu¹，Yushan Wang¹，Chuan Hu¹，Wenqi Yu¹，Yang Zhou¹，Ling Wang¹，Mengjiao Zhang¹，Huile Gao¹，Xiang Gao²（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry,Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology,West China School of Pharmacy,Sichuan University；Department of Neurosurgery and Institute of Neurosurgery,State Key Laboratory of Biotherapy,West China Hospital,West China Medical School,Sichuan University and Collaborative Innovation Center for Biotherapy）.Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer[J].Acta Pharmaceutica Sinica B,2022,第8期 Zhejie Chen^1,2，Wei Hao^1,2，Caifang Gao¹，Yangyang Zhou¹，Chen Zhang³，Jinming Zhang³，Ruibing Wang¹，Yitao Wang^1,2，Shengpeng Wang^1,2（State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau；Macau Centre for Research and Development in Chinese Medicine,University of Macau；College of Pharmacy,Chengdu University of Traditional Chinese Medicine）.A polyphenol-assisted IL-10 mRNA delivery system for ulcerative colitis[J].Acta Pharmaceutica Sinica B,2022,第8期 Tingting Li¹，Jie Pan²，Hongqi Chen³，Yongliang Fang⁴，Yang Sun^2,5（Department of Gastroenterology,the Second Medical Center,National Clinical Research Center for Geriatric Diseases,State Key Laboratory of Kidney Diseases,Chinese PLA General Hospital；State Key Laboratory of Pharmaceutical Biotechnology,Department of Biotechnology and Pharmaceutical Sciences,School of Life Sciences,Nanjing University；Department of General Surgery,Shanghai Jiao Tong University Affiliated Sixth People's Hospital；Department of Urology,Boston Children's Hospital,Departments of Microbiology and Surgery,Harvard Medical School；Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy,Xuzhou Medical University）.CXCR6-based immunotherapy in autoimmune,cancer and inflammatory infliction[J].Acta Pharmaceutica Sinica B,2022,第8期 Yingping Zeng，Sufen Li，Shufen Zhang，Li Wang，Hong Yuan，Fuqiang Hu（College of Pharmaceutical Science,Zhejiang University）.Cell membrane coated-nanoparticles for cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2022,第8期 Rongfang Wei^1,2，Xing Cui³，Jie Min²，Zigen Lin²，Yanyan Zhou²，Mengjie Guo²，Xiaojuan An²，Hao Liu²，Siegfried Janz⁴，Chunyan Gu^1,2，Hongbo Wang^5,6，Ye Yang²（Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine；School of Medicine & Holistic Integrative Medicine,Nanjing University of Chinese Medicine；Department of Hematology,Affiliated Hospital of Shandong University of Traditional Chinese Medicine；Division of Hematology and Oncology,Medical College of Wisconsin；School of Pharmacy,Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University)，Ministry of Education,Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong,Yantai University；Bohai Rim Advanced Research Institute for Drug Discovery）.NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma[J].Acta Pharmaceutica Sinica B,2022,第8期 Dan Liu^1,2，Jianpeng Huang¹，Shanshan Gao¹，Hongtao Jin^3,4，Jiuming He^1,4（State Key Laboratory of Bioactive Substance and Function of Natural Medicines,Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Clinical Pharmacy,First People's Hospital of Huaihua；New Drug Safety Evaluation Center,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College；NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drug）.A temporo-spatial pharmacometabolomics method to characterize pharmacokinetics and pharmacodynamics in the brain microregions by using ambient mass spectrometry imaging[J].Acta Pharmaceutica Sinica B,2022,第8期 Minglu Zhou，Qingting Zuo，Yuan Huang，Lian Li（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology,West China School of Pharmacy,Sichuan University）.Immunogenic hydrogel toolkit disturbing residual tumor “seeds” and pre-metastatic “soil” for inhibition of postoperative tumor recurrence and metastasis[J].Acta Pharmaceutica Sinica B,2022,第8期 Cuixia Zheng¹，Xinxin Liu^2,1，Yueyue Kong¹，Lei Zhang³，Qingling Song¹，Hongjuan Zhao¹，Lu Han¹，Jiannan Jiao¹，Qianhua Feng^1,4，Lei Wang^2,1,4,5（School of Pharmaceutical Sciences,Zhengzhou University；Luoyang Central Hospital Affiliated to Zhengzhou University；Department of Gynecology,the First Affiliated Hospital of Zhengzhou University；Key Laboratory of Advanced Drug Preparation Technologies,Ministry of Education,School of Pharmaceutical Sciences,Zhengzhou University；Tumor Immunity and Biomaterials Advanced Medical Center,Zhengzhou University）.Hyperthermia based individual in situ recombinant vaccine enhances lymph nodes drainage for de novo antitumor immunity[J].Acta Pharmaceutica Sinica B,2022,第8期 Honglin Tang^1,2，Yanan Xue^1,2，Bowen Li²，Xiaojie Xu²，Fu Zhang^1,3，Jiajing Guo²，Qijun Li¹，Tingting Yuan²，Yuan Chen²，Yubin Pan¹，Yuan Ping²，Da Li¹（Department of Medical Oncology,Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University；College of Pharmaceutical Sciences,Zhejiang University；Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital,Zhejiang University）.Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma[J].Acta Pharmaceutica Sinica B,2022,第8期 Longlong Zhang^1,2，Yuefei Zhu¹，Xunbin Wei³，Xing Chen^1,2，Yang Li^1,2，Ying Zhu¹，Jiaxuan Xia¹，Yiheng Huang¹，Yongzhuo Huang⁴，Jianxin Wang^1,2,5，Zhiqing Pang^1,2（Department of Pharmaceutics,School of Pharmacy,Fudan University；Key Laboratory of Smart Drug Delivery,Ministry of Education；State Key Laboratory of Oncogenes and Related Genes,Shanghai Cancer Institute,Med-X Research Institute and School of Biomedical Engineering,Shanghai Jiao Tong University；State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences；Institute of Materia Medica,Academy of Chinese and Western Integrative Medicine,Fudan University）.Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model[J].Acta Pharmaceutica Sinica B,2022,第8期 Wenbin Kuang^1,2，Haolin Zhang^1,2，Xiao Wang^1,2，Peng Yang^1,2（State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization,China Pharmaceutical University；Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University）.Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis[J].Acta Pharmaceutica Sinica B,2022,第8期 Yaosheng Li¹，Honghui Wu¹，Xinchi Jiang^1,2，Yunfei Dong¹，Juanjuan Zheng¹，Jianqing Gao^1,2,3（Institute of Pharmaceutics,College of Pharmaceutical Sciences,Zhejiang University；Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine,Zhejiang University；Hangzhou Institute of Innovative Medicine,Zhejiang University）.New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders：Combining with intranasal delivery[J].Acta Pharmaceutica Sinica B,2022,第8期 Sai-Qi Wang^1,2，Qiu-Xu Teng³，Shuai Wang⁴，Zi-Ning Lei³，Hui-Hui Hu¹，Hui-Fang Lv¹，Bei-Bei Chen¹，Jian-Zheng Wang¹，Xiao-Jing Shi⁵，Wei-Feng Xu¹，Hong-Min Liu^4,2，Xiao-Bing Chen^1,2，Zhe-Sheng Chen³，Bin Yu^4,2（Department of Oncology,the Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Henan Cancer Institute；State Key Laboratory of Esophageal Cancer Prevention & Treatment,Zhengzhou University；College of Pharmacy and Health Sciences,St. John's University；School of Pharmaceutical Sciences,Zhengzhou University；Laboratory Animal Center,Academy of Medical Science,Zhengzhou University）.Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent,specific and orally active P-glycoprotein（P-gp）inhibitor[J].Acta Pharmaceutica Sinica B,2022,第8期首页上一页 1 2 3 4 5 下一页尾页共有11页，转到页

期刊文章列表